Literature DB >> 16205787

Effects of ultrafine and fine particulate and gaseous air pollution on cardiac autonomic control in subjects with coronary artery disease: the ULTRA study.

Kirsi L Timonen1, Esko Vanninen, Jeroen de Hartog, Angela Ibald-Mulli, Bert Brunekreef, Diane R Gold, Joachim Heinrich, Gerard Hoek, Timo Lanki, Annette Peters, Tuula Tarkiainen, Pekka Tiittanen, Wolfgang Kreyling, Juha Pekkanen.   

Abstract

Previous studies have shown an association between elevated concentrations of particulate air pollution and cardiovascular morbidity and mortality. Therefore, the association between daily variation of ultrafine and fine particulate air pollution and cardiac autonomic control measured as heart rate variability (HRV) was studied in a large multicenter study in Amsterdam, the Netherlands, Erfurt, Germany, and Helsinki, Finland. Elderly subjects (n=37 in Amsterdam, n=47 in both Erfurt and Helsinki) with stable coronary artery disease were followed for 6 months with biweekly clinical visits. During the visits, ambulatory electrocardiogram was recorded during a standardized protocol including a 5-min period of paced breathing. Time and frequency domain analyses of HRV were performed. A statistical model was built for each center separately. The mean 24-h particle number concentration (NC) (1,000/cm(3)) of ultrafine particles (diameter 0.01-0.1 microm) was 17.3 in Amsterdam, 21.1 in Erfurt, and 17.0 in Helsinki. The corresponding values for PM2.5 were 20.0, 23.1, and 12.7 microg/m(3). During paced breathing, ultrafine particles, NO(2), and CO were at lags of 0-2 days consistently and significantly associated with decreased low-to-high frequency ratio (LF/HF), a measure of sympathovagal balance. In a pooled analysis across the centers, LF/HF decreased by 13.5% (95% confidence interval: -20.1%, -7.0%) for each 10,000/cm(3) increase in the NC of ultrafine particles (2-day lag). PM2.5 was associated with reduced HF and increased LF/HF in Helsinki, whereas the opposite was true in Erfurt, and in Amsterdam, there were no clear associations between PM2.5 and HRV. The results suggest that the cardiovascular effects of ambient ultrafine and PM2.5 can differ from each other and that their effect may be modified by the characteristics of the exposed subjects and the sources of PM2.5.

Entities:  

Mesh:

Year:  2005        PMID: 16205787     DOI: 10.1038/sj.jea.7500460

Source DB:  PubMed          Journal:  J Expo Sci Environ Epidemiol        ISSN: 1559-0631            Impact factor:   5.563


  49 in total

1.  Association of air pollution sources and aldehydes with biomarkers of blood coagulation, pulmonary inflammation, and systemic oxidative stress.

Authors:  Brent Altemose; Mark G Robson; Howard M Kipen; Pamela Ohman Strickland; Qingyu Meng; Jicheng Gong; Wei Huang; Guangfa Wang; David Q Rich; Tong Zhu; Junfeng Zhang
Journal:  J Expo Sci Environ Epidemiol       Date:  2016-07-20       Impact factor: 5.563

2.  Individual PM2.5 exposure is associated with the impairment of cardiac autonomic modulation in general residents.

Authors:  Yuquan Xie; Liang Bo; Shuo Jiang; Zhenyong Tian; Haidong Kan; Yigang Li; Weimin Song; Jinzhuo Zhao
Journal:  Environ Sci Pollut Res Int       Date:  2016-02-24       Impact factor: 4.223

3.  Effects of fine particulate on heart rate variability in Beijing: a panel study of healthy elderly subjects.

Authors:  Xiaofeng Jia; Xiaoming Song; Masayuki Shima; Kenji Tamura; Furong Deng; Xinbiao Guo
Journal:  Int Arch Occup Environ Health       Date:  2011-05-15       Impact factor: 3.015

4.  Genome-wide transcriptional analysis of cardiovascular-related genes and pathways induced by PM2.5 in human myocardial cells.

Authors:  Lin Feng; Xiaozhe Yang; Collins Otieno Asweto; Jing Wu; Yannan Zhang; Hejing Hu; Yanfeng Shi; Junchao Duan; Zhiwei Sun
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-22       Impact factor: 4.223

5.  Recovery from stress: an experimental examination of focused attention meditation in novices.

Authors:  Amy R Borchardt; Peggy M Zoccola
Journal:  J Behav Med       Date:  2018-05-30

Review 6.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

7.  Association of biomarkers of systemic inflammation with organic components and source tracers in quasi-ultrafine particles.

Authors:  Ralph J Delfino; Norbert Staimer; Thomas Tjoa; Mohammad Arhami; Andrea Polidori; Daniel L Gillen; Michael T Kleinman; James J Schauer; Constantinos Sioutas
Journal:  Environ Health Perspect       Date:  2010-02-02       Impact factor: 9.031

8.  Increased non-conducted P-wave arrhythmias after a single oil fly ash inhalation exposure in hypertensive rats.

Authors:  Aimen K Farraj; Najwa Haykal-Coates; Darrell W Winsett; Mehdi S Hazari; Alex P Carll; William H Rowan; Allen D Ledbetter; Wayne E Cascio; Daniel L Costa
Journal:  Environ Health Perspect       Date:  2008-12-31       Impact factor: 9.031

9.  Associations between PM2.5 and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart disease.

Authors:  Jeroen J de Hartog; Timo Lanki; Kirsi L Timonen; Gerard Hoek; Nicole A H Janssen; Angela Ibald-Mulli; Annette Peters; Joachim Heinrich; Tuula H Tarkiainen; Rene van Grieken; Joop H van Wijnen; Bert Brunekreef; Juha Pekkanen
Journal:  Environ Health Perspect       Date:  2008-08-25       Impact factor: 9.031

10.  Reduction in heart rate variability with traffic and air pollution in patients with coronary artery disease.

Authors:  Antonella Zanobetti; Diane R Gold; Peter H Stone; Helen H Suh; Joel Schwartz; Brent A Coull; Frank E Speizer
Journal:  Environ Health Perspect       Date:  2009-11-18       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.